Similarly, contrasting results have also been reported in studies on TNF-α inhibitors, which initially showed impressive protection when tested in murine models of LPS-induced sepsis, but subsequent human studies have failed to show any benefit in mortality. The gene discussed is TNF; the disease is Sepsis.